達安基因(002030.SZ)3天2板:核酸檢測產品對公司業績影響的持續性目前尚無法估計
格隆匯6月17日丨達安基因(002030.SZ)公佈,公司股票交易價格連續三個交易日內(2020年6月15日、2020年6月16日、2020年6月17日)收盤價格漲幅偏離值累計達到20%以上。
受新型冠狀病毒肺炎疫情影響,市場對新型冠狀病毒(2019-nCoV)核酸檢測試劑盒及核酸檢測儀器、相關耗材的需求量大幅度增長,對公司業績產生了積極影響。公司以自主開發、完整貫通的核酸檢測技術全產業鏈平台,啟動充足的產能提供新型冠狀病毒核酸檢測產品,全力保障市場供給。鑑於新型冠狀病毒肺炎疫情發展、產品的非唯一性、同類產品競爭以及產品價格波動等不確定因素的影響,上述核酸檢測產品對公司業績影響的持續性目前尚無法估計,請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.